Numinus Completes First Legal Harvest of Psychedelic Mushrooms

Numinus Wellness (TSXV: NUMI) has become the first publicly issued firm to legally complete a harvest of psilocybe mushrooms. The company announced this morning that it has completed its first harvest of the psychedelic mushrooms from its 7,000 square foot facility.

With the process of cultivation completed, the company has now prepared the harvest for freeze drying, which is said to be the first step to discovery and development of standardized testing. With Numinus focused on handling and development of analytical methods and formulations for the psychedelics space, the next step is said to be the research and development of these methods.

Numinus is said to be focused on natural forms of psilocybin, rather than synthetically produced variants. The company comments on the affordability of natural versions versus that of synthetic, and how price considerations are significant when it comes to ensuring accessibility of the medicine.

Naturally, however, given the focus on analytical testing for psychedelic substances, this mantra of a focus on natural production methods better suits the firms business plan. Outside of the harvest, Numinus also announced today that it has submitted an amended application for its Health Canada issued Controlled Drugs and Substances License.

Under the amended application, the company is looking to be approved for the sale of Psilocybe mushroom fruiting bodies and extract for clinical research protocols, as well as for standardized testing for additional psychedelics. Currently, the firms license allows for the testing, import, export, storage and distribution of MDMA, psilocybni, psilocin, DMT, and mescaline as well as for certain research initiatives.

Numinus Wellness last traded at $0.40 on the TSX Venture.


Information for this briefing was found via Sedar and Numinus Wellness. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Leave a Reply

Video Articles

Endeavour Mining Q1 Earnings: Cash Flow Is King

G Mining Oko West Feasibility: Move Fast, Break.. Nothing?

New Gold Q1 Earnings: What’s Behind The Market’s Surprising Reaction?

Recommended

First Majestic Posts Record Cash Flows In Q1 As Production Costs Fall

Brazil Potash Secures Funding In Support Of US$2.5 Billion Autozales Project

Related News

Numinus Wellness To Acquire MedBright AI In Bid To Add Artificial Intelligence To Portfolio

Numinus Wellness (TSX: NUMI) is set to get into the artificial intelligence business. The firm...

Thursday, June 20, 2024, 09:41:47 AM

Numinus Wellness To Conduct $10.0 Million Bought Deal

Numinus Wellness (TSXV: NUMI) evidently is seeing strong investor demand, with the psychedelics firm this...

Monday, December 7, 2020, 07:38:26 AM

Numinus Wellness Walks From Acquisition Of MedBright AI

Numinus Wellness (TSX: NUMI) has walked away from a plan to add artificial intelligence assets...

Monday, August 12, 2024, 10:08:35 AM

Numinus Wellness To Undertake Phase 1 Study Of Psilocybin Extract

Numinus Wellness (TSXV: NUMI) is undertaking further studies of its psilocybin products. The company this...

Monday, April 26, 2021, 07:10:35 AM

Numinus Wellness Halts Stock For Trading Day To Announce $17 Million Financing Closing

After halting trading in its equity all day, Numinus Wellness (TSXV: NUMI) this evening finally...

Tuesday, December 29, 2020, 04:49:21 PM